Type
. Relapse rates following leprosy multidrug therapy. The West Indian medical journal. 2000;49(3):210-1.
Type
. Clinico-histopathological concordance in leprosy. Tropical doctor. 2000;30(4):228-31.
Type
. Immunity to Mycobacterium leprae infections in mice stimulated by M. leprae, BCG, and graft-versus-host reactions. Infection and immunity [Internet]. 1976;14(4):919-28. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC415472/pdf/iai00226-0069.pdf
Type
. Importance of nasal lesions in early lepromatous leprosy. Annals of the Royal College of Surgeons of England. 1975;57(6):309-12.
Type
. Multicentre controlled comparative trial of clofazimine and dapsone in low dosages. Leprosy review [Internet]. 1975;46(4):287-96. Available from: http://leprev.ilsl.br/pdfs/1975/v46n4/pdf/v46n4a05.pdf
Type
. The fly as potential vector in the transmission of leprosy. Leprosy review [Internet]. 1975;46(4):279-86. Available from: http://leprev.ilsl.br/pdfs/1975/v46n4/pdf/v46n4a04.pdf
Type
. Lepromatous leprosy in the nose after one year of dapsone treatment: histopathological findings. Leprosy review [Internet]. 1975;46(4):267-77. Available from: http://leprev.ilsl.br/pdfs/1975/v46n4/pdf/v46n4a03.pdf
Type
. Lepromatous leprosy in the nose after one year of dapsone treatment: clinical and bacteriological findings. Leprosy review [Internet]. 1975;46(4):257-65. Available from: http://leprev.ilsl.br/pdfs/1975/v46n4/pdf/v46n4a02.pdf
Type
. Erythema nodosum leprosum in a general hospital. Archives of dermatology. 1975;111(12):1575-80.
Type
. Minimal inhibitory concentration of dapsone for Mycobacterium leprae in rats. Antimicrobial agents and chemotherapy. 1975;8(5):551-7.